Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

Drug Marketing to Doctors: Changes May Be On the Way Image

Drug Marketing to Doctors: Changes May Be On the Way

Janice G. Inman

The cornerstone of many FDA enforcement actions against pharmaceuticals manufacturers in recent years has been the charge that they have "misbranded" their pharmaceutical products by promoting them for uses not approved by the FDA. Now, the Second Circuit has thrown the concept of criminal liability for misbranding by means of off-label-use promotion into turmoil.

Verdicts Image

Verdicts

ALM Staff & Law Journal Newsletters

Analysis of two important rulings.

Features

Drug & Device News Image

Drug & Device News

ALM Staff & Law Journal Newsletters

A discussion of several key cases.

Med Mal News Image

Med Mal News

ALM Staff & Law Journal Newsletters

Several items of interest.

HITECH and HIPAA Enforcement Activities Image

HITECH and HIPAA Enforcement Activities

ALM Staff & Law Journal Newsletters

The OCR is putting new emphasis on enforcing patient privacy rights since the passage of HITECH in 2009. A look at four settlement agreements.

Features

Filing Whistleblower Actions to Avoid Peer Review Image

Filing Whistleblower Actions to Avoid Peer Review

David M. Axelrad, Peder K. Batalden & H. Thomas Watson

The California Supreme Court has taken a keen interest in the peer-review process in recent years. Here's why.

Undoing Pliva Inc. v. Mensing Image

Undoing Pliva Inc. v. Mensing

Josh Becker & Travis Thompson

This article examines the relationship between <i>Pliva</i> and the Patient Safety and Generic Labeling Improvement Act, and discusses the potential ramifications for generic drug manufacturers should the Act be signed into law.

Verdicts Image

Verdicts

ALM Staff & Law Journal Newsletters

Recent rulings of importance.

Features

Med Mal News Image

Med Mal News

ALM Staff & Law Journal Newsletters

All the latest news.

Drug & Device News Image

Drug & Device News

ALM Staff & Law Journal Newsletters

A look at what's new.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Strategy vs. Tactics: Two Sides of a Difficult Coin
    With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
    Read More ›
  • Major Differences In UK, U.S. Copyright Laws
    This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
    Read More ›
  • The Article 8 Opt In
    The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
    Read More ›
  • The Unlicensed Real Estate Broker in New York: Beware
    The U.S. District Court for the Northern District of New York recently determined that because New York prohibits unlicensed real estate brokers from pursuing payment in its courts for services rendered, a plaintiff who performed real estate work for a client who then did not pay had no standing to sue.
    Read More ›